stoxline Quote Chart Rank Option Currency Glossary
  
cbdMD, Inc. (YCBD)
0.685  0.022 (3.38%)    05-28 15:13
Open: 0.68
High: 0.69
Volume: 51,485
  
Pre. Close: 0.663
Low: 0.65
Market Cap: 3(M)
Technical analysis
2024-05-28 2:55:46 PM
Short term     
Mid term     
Targets 6-month :  1.19 1-year :  1.46
Resists First :  1.02 Second :  1.25
Pivot price 0.71
Supports First :  0.64 Second :  0.54
MAs MA(5) :  0.68 MA(20) :  0.76
MA(100) :  0.79 MA(250) :  0.99
MACD MACD :  -0.1 Signal :  -0.1
%K %D K(14,3) :  9.9 D(3) :  10.8
RSI RSI(14): 39.5
52-week High :  2.19 Low :  0.56
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ YCBD ] has closed above bottom band by 35.1%. Bollinger Bands are 43.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 0.72 - 0.73 0.73 - 0.73
Low: 0.65 - 0.66 0.66 - 0.66
Close: 0.66 - 0.66 0.66 - 0.67
Company Description

cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, bath bombs, bath salts, and sleep aids. It also offers veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name. The company distributes its products through its e-commerce Website, third-party e-commerce sites, wholesalers, and various brick and mortar retailers in the United States. It has a research partnership with the University of Mississippi to identify novel cannabinoids. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. was incorporated in 2015 and is headquartered in Charlotte, North Carolina.

Headline News

Thu, 16 May 2024
cbdMD loss widens as sales slump in the second quarter - Green Market Report

Thu, 16 May 2024
cbdMD Launches Max Chill Dragon Fruit D9 Gummies: Your Go-To Relaxation Blend for the Summer - Yahoo Finance

Wed, 15 May 2024
cbdMD's Financial Results: Cost-Cutting Measures For Positive Cash Flow Amid Increasing Losses - cbdMD (A - Benzinga

Wed, 15 May 2024
cbdMD Reports Second Quarter Results - Yahoo Finance

Mon, 13 May 2024
cbdMD, Inc. to Host Conference Call to Discuss Second Quarter of Fiscal 2024 Results - Yahoo Finance

Tue, 09 Apr 2024
Former CBD CEO, SEC reach agreement over deals that falsely boosted company's value - HempToday

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Underperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
AMEX
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Shares Out 3 (M)
Shares Float 2 (M)
Held by Insiders 17.9 (%)
Held by Institutions 6 (%)
Shares Short 267 (K)
Shares Short P.Month 296 (K)
Stock Financials
EPS -15.65
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 9.01
Profit Margin -82.5 %
Operating Margin -29.8 %
Return on Assets (ttm) -13 %
Return on Equity (ttm) -60 %
Qtrly Rev. Growth -28.8 %
Gross Profit (p.s.) 7.81
Sales Per Share 9.19
EBITDA (p.s.) -2.73
Qtrly Earnings Growth 0 %
Operating Cash Flow -6 (M)
Levered Free Cash Flow -2 (M)
Stock Valuations
PE Ratio -0.05
PEG Ratio 0
Price to Book value 0.07
Price to Sales 0.07
Price to Cash Flow -0.34
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android